And the FDA has approved Amgen’s Uplizna for adults with antibody-positive generalized myasthenia gravis, adding a ...

Explore how expanding clinical trials into community and nontraditional sites, simplifying protocols, and leveraging AI can ...

Many people suffer from acne problems and other skin issues, which could be recurring in nature. But skincare looks different today, and so do its treatments. While products were fewer and simpler in ...

Ruxolitinib demonstrated sustained efficacy and improved quality of life in myelofibrosis patients in a real-world setting. The JAKoMo study reported fewer adverse events than clinical trials, ...